• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

双膦酸盐相关颌骨坏死的临床研究

[Clinical investigation of bisphosphonate-related osteonecrosis of the jaws].

作者信息

Dehari Hironari, Tomihara Kei, Ueda Megumi, Shimanishi Makoto, Ono Masayuki, Sasaki Takanori, Igarashi Tomohiro, Shiratori Kaori, Abe Masato, Ogi Kazuhiro, Nakamori Kenji, Miyazaki Akihiro, Nagai Itaru, Hiratsuka Hiroyoshi

机构信息

Dept. of Oral Surgery, Sapporo Medical University School of Medicine.

出版信息

Gan To Kagaku Ryoho. 2009 Dec;36(13):2587-92.

PMID:20009460
Abstract

We examined the clinical features of bisphosphonate(BP)-related osteonecrosis of the jaws(BRONJ), a serious complication resulting from intravenous BP treatment for multiple myeloma and malignant tumors with bone metastasis. We retrospectively reviewed the medical records of 36 patients who received intravenous BP therapy for the above-mentioned conditions, at Sapporo Medical University Hospital between July 2006 and October 2008. BP therapy caused BRONJ in 7 of 24 patients, but did not affect the bones of the other 17 patients. The other 12 of the 36 patients involved in the study were prescribed BP only after they had undergone an oral examination and treatment for dental inflammation. Of these patients, 7 developed BRONJ with BP treatment, after tooth extraction or acute dental inflammation. Treating dental inflammation before prescribing BP prevented the development of BRONJ. BRONJ is highly intractable and does not resolve with the standard treatment for osteomyelitis. Therefore, preventive therapy, which can be achieved by cooperation between medical doctors and dentists, is currently the most effective strategy for BRONJ. Conservative treatment with antibiotics may also be useful for maintaining or improving the quality of life of BRONJ patients.

摘要

我们研究了双膦酸盐(BP)相关颌骨骨坏死(BRONJ)的临床特征,这是一种因静脉注射BP治疗多发性骨髓瘤和伴有骨转移的恶性肿瘤而导致的严重并发症。我们回顾性分析了2006年7月至2008年10月期间在札幌医科大学医院接受上述静脉BP治疗的36例患者的病历。BP治疗导致24例患者中的7例发生BRONJ,但对其他17例患者的骨骼未产生影响。参与研究的36例患者中的另外12例仅在接受口腔检查和治疗牙齿炎症后才使用BP。在这些患者中,7例在拔牙或急性牙齿炎症后因BP治疗而发生BRONJ。在开BP之前治疗牙齿炎症可预防BRONJ的发生。BRONJ极难治疗,采用骨髓炎的标准治疗方法无法治愈。因此,目前通过医生和牙医合作实现的预防性治疗是BRONJ最有效的策略。使用抗生素进行保守治疗可能也有助于维持或改善BRONJ患者的生活质量。

相似文献

1
[Clinical investigation of bisphosphonate-related osteonecrosis of the jaws].双膦酸盐相关颌骨坏死的临床研究
Gan To Kagaku Ryoho. 2009 Dec;36(13):2587-92.
2
Intravenous bisphosphonate therapy and bisphosphonate-related osteonecrosis of the jaws.静脉注射双膦酸盐治疗与双膦酸盐相关的颌骨坏死
J Oral Maxillofac Surg. 2009 May;67(5 Suppl):44-52. doi: 10.1016/j.joms.2008.12.004.
3
Oral bisphosphonates as a cause of bisphosphonate-related osteonecrosis of the jaws: clinical findings, assessment of risks, and preventive strategies.口服双膦酸盐作为颌骨双膦酸盐相关骨坏死的一个病因:临床发现、风险评估及预防策略。
J Oral Maxillofac Surg. 2009 May;67(5 Suppl):35-43. doi: 10.1016/j.joms.2009.01.003.
4
The role of surgical resection in the management of bisphosphonate-related osteonecrosis of the jaws.手术切除在双膦酸盐相关颌骨骨坏死治疗中的作用。
J Oral Maxillofac Surg. 2009 May;67(5 Suppl):85-95. doi: 10.1016/j.joms.2009.01.006.
5
Bisphosphonate-related osteonecrosis of the jaw: clinical features, risk factors, management, and treatment outcomes of 26 patients.双膦酸盐相关颌骨坏死:26例患者的临床特征、危险因素、管理及治疗结果
J Oral Maxillofac Surg. 2009 Sep;67(9):1904-13. doi: 10.1016/j.joms.2009.04.051.
6
Nationwide survey for bisphosphonate-related osteonecrosis of the jaws in Japan.日本全国范围内双膦酸盐相关颌骨坏死的调查。
J Oral Maxillofac Surg. 2011 Nov;69(11):e364-71. doi: 10.1016/j.joms.2011.03.051. Epub 2011 Jul 23.
7
[New development in bisphosphonate treatment. Bisphosphonate therapy and osteonecrosis of the jaws].[双膦酸盐治疗的新进展。双膦酸盐治疗与颌骨坏死]
Clin Calcium. 2009 Jan;19(1):100-8.
8
Serologic bone markers for predicting development of osteonecrosis of the jaw in patients receiving bisphosphonates.用于预测接受双膦酸盐治疗患者颌骨坏死发生情况的血清学骨标志物。
J Oral Maxillofac Surg. 2010 Sep;68(9):2241-7. doi: 10.1016/j.joms.2010.05.043.
9
Bisphosphonate-induced avascular osteonecrosis of the jaws: a clinical report of 11 cases.双膦酸盐所致颌骨无血管性骨坏死:11例临床报告
Int J Oral Maxillofac Surg. 2006 Jul;35(7):588-93. doi: 10.1016/j.ijom.2006.02.022. Epub 2006 May 9.
10
Outcome of surgical management of bisphosphonate-related osteonecrosis of the jaws: review of 33 surgical cases.双膦酸盐相关颌骨骨坏死的外科治疗结果:33例手术病例回顾
J Oral Maxillofac Surg. 2009 May;67(5):943-50. doi: 10.1016/j.joms.2008.12.057.

引用本文的文献

1
Augmentation of IFN-γ by bone marrow derived immune cells in the presence of severe suppression of IFN-γ in gingivae induced by zoledronic acid and denosumab in Hu-BLT mice model of ONJ.唑来膦酸和地舒单抗在 Hu-BLT 模型中诱导牙龈 IFN-γ 严重抑制的情况下,骨髓来源免疫细胞对 IFN-γ 的增强作用。
Front Endocrinol (Lausanne). 2023 Jan 20;14:1111627. doi: 10.3389/fendo.2023.1111627. eCollection 2023.